![]()
BRS4-1-2 - NAD⁺ Metabolism
(Keeping Cellular Energy Chemistry Charged)
1. Mission & Overview + Dietary Levers
Mission
Maintain NAD⁺ availability so redox reactions and mitochondrial signalling stay adequately powered.
Intervention Dominance: Diet-Supported
-
Nicotinamide riboside
-
Nicotinamide (a form of vitamin B3)
-
Nicotinic acid (a form of vitamin B3)
-
Tryptophan
No evidence-supported cofactors or substrates are currently established for this mechanism.
No mapping established.
Overview
NAD⁺ helps cells release energy from nutrients and supports enzymes involved in maintenance and repair. Cells must continually recycle and replenish this molecule to keep those functions available. This PM focuses on maintaining that cellular resource. Dietary vitamin B3 forms and tryptophan provide building material, while exercise can influence part of the recycling machinery. Supporting normal availability is different from assuming that raising NAD⁺ improves cognition or wellbeing. [1] [3] [6]
- Benefits: Maintaining NAD⁺ supports energy metabolism and cellular repair—functions needed for healthy tissue function. This explains the value of the mechanism, rather than demonstrating a benefit from extra intake. [1] [3]
- Implementation Notes: The dietary disclosures identify the specific vitamin B3 forms and tryptophan that supply this pool. Aerobic or resistance training increased a recycling enzyme in human muscle; high-dose niacin evidence comes from mitochondrial disease and does not establish a routine supplement regimen. [1] [2] [6]
- Biological Relevance: This resource connects mitochondrial energy metabolism with cellular maintenance and repair. It also interacts with biological timing mechanisms, linking energy regulation with the body’s daily rhythms. [1] [3] [4]
2. Primary Biological Effects
NAD⁺ is reduced to NADH in dehydrogenase reactions, and that NADH can be oxidised back to NAD⁺
Synthesis and salvage replenish NAD⁺ when consuming enzymes break the molecule down
Nicotinamide salvage, the nicotinic-acid route and hepatic tryptophan conversion are major precursor pathways
3. Intervention Levers
No preparation method, meal pairing, or cooking step has been shown to change NAD⁺ availability.
Keeping a regular sleep schedule has not been shown to change NAD⁺ availability in people.
- Aerobic or resistance training
4. Mechanistic Basis
Summary
NAD⁺ accepts electrons to form NADH, which can be oxidised back to NAD⁺ [Covarrubias et al. (2021) [1]]. Separately, synthesis and salvage replenish the pool when consuming enzymes break the molecule down [Chang and Guarente (2014) [3]]. Nicotinamide salvage, the nicotinic-acid route and hepatic tryptophan conversion are major pathways [Covarrubias et al. (2021) [1]]. In mice, the clock controls the salvage enzyme NAMPT [Ramsey et al. (2009) [4]]. High-dose niacin raised NAD⁺ in mitochondrial myopathy [Pirinen et al. (2020) [2]]. Training raised the muscle enzyme, not measured NAD⁺ [de Guia et al. (2019) [6]].
Mechanism and measurement boundaries
This PM includes NAD⁺ replenishment, redox use and enzymatic consumption. Electron transport and the creatine buffer are distinct mechanisms. [1]
The precursor pathways are supported by reviewed mechanistic evidence. The high-dose niacin study involved five adults with mitochondrial myopathy; exercise measured muscle NAMPT protein, not NAD⁺ concentration or brain function. These endpoints do not establish improved cognitive energy or recovery. [1] [2] [6]
4.1 Scientific Findings (6)
Summary
NAD⁺ and NADH interconvert in dehydrogenase reactions. Separately, synthesis and salvage replenish the pool when consuming enzymes break NAD⁺ down. Nicotinamide salvage, the nicotinic-acid route and hepatic tryptophan conversion are major pathways, not every precursor entry. The findings separate that chemistry from a high-dose niacin study in mitochondrial myopathy, from a muscle-enzyme response to training, and from the absence of an NAD⁺ measurement in the ADHD papers.
NAD⁺ accepts electrons to form NADH, and that NADH can be oxidised back to NAD⁺. Separately, nicotinamide salvage, the nicotinic-acid route and hepatic conversion of tryptophan are major pathways that replenish the pool when consuming enzymes break NAD⁺ down.
What this means
These are major maintenance pathways, not every precursor entry. Identifying them does not show that eating more of a precursor, once intake is adequate, raises NAD⁺ or improves attention.
Evidence confidence: Not yet scored
Finding ID: PM2-F1
Finding Statement: Major pathways that maintain the mammalian NAD⁺ pool are de novo synthesis from tryptophan, the Preiss–Handler route from nicotinic acid, and salvage of nicotinamide. Most cells outside the liver depend on salvage. These are not the only precursor entry routes.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The review describes NAD⁺ as the coenzyme that accepts a hydride in redox reactions. It is synthesised de novo from tryptophan through the kynurenine pathway, from nicotinic acid by the Preiss–Handler pathway, and by salvage of nicotinamide. Outside the liver, most cells do not express the full tryptophan route. The liver can convert tryptophan to nicotinamide, release it, and leave other cells to salvage that nicotinamide. The review states that the share of the pool coming from tryptophan is not established. Most NAD⁺ is described as coming from nicotinamide salvage.
Synthesis Limitations: This is a review of pathways, not a human feeding trial. It does not measure how much an ordinary meal changes NAD⁺, and it does not test attention or cognitive energy. Nicotinamide riboside and nicotinamide mononucleotide, as supplement doses, are outside this dietary assessment.
Evidence Considered:
- Study
- Review of NAD⁺ biosynthesis and of NAD⁺-dependent enzymes in energy metabolism and ageing.
- Population
- No new human feeding cohort. Review of biochemical and organism studies.
- Result
- Three biosynthetic routes are distinguished. Nicotinamide salvage supplies most NAD⁺ outside the liver. The contribution of tryptophan is not established.
- Effect / Magnitude
- No ordinary-diet effect size.
- Evidence Summary
- Defines major pathways that maintain the NAD⁺ pool, not every precursor entry.
- Limitations
- A review does not test meals, adequate versus extra intake, or cognitive outcomes.
- Evidence Source
- Bounded external search
- Reference
- [1]
Connected / Supportive Evidence:
- Tardy et al. (2020) [9] — MechanisticWhy relevant: Reviews B vitamins among cofactors linked to energy metabolism and fatigue.Why excluded from the primary synthesis: It does not define the NAD⁺ biosynthetic enzymes or measure NAD⁺.
- Kyriazis et al. (2022) [10] — MechanisticWhy relevant: Reviews how several diet patterns relate to mitochondrial function, biogenesis and turnover.Why excluded from the primary synthesis: It does not establish the NAD⁺ biosynthetic routes or a change in NAD⁺ availability.
Informs: Cognitive Energy Stability
NAD⁺ is not only a redox cofactor. Sirtuins, CD38 and poly(ADP-ribose) polymerases consume it during protein deacylation, signalling and repair.
What this means
Consumption explains why the pool can fall. It does not show that blocking these enzymes, or eating more niacin, improves attention.
Evidence confidence: Not yet scored
Finding ID: PM2-F2
Finding Statement: NAD⁺ is a substrate of non-redox enzymes, including sirtuins, CD38 and poly(ADP-ribose) polymerases, as well as a hydride acceptor in energy metabolism.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The NAD⁺ review identifies sirtuins, CD38 and poly(ADP-ribose) polymerases as enzymes that use NAD⁺ itself, separate from its redox role. A sirtuin review describes SIRT1 as an NAD⁺-dependent deacetylase that links this consumption to metabolic regulation. Together they place consumption on the same pool that biosynthesis rebuilds. They do not measure a dietary dose.
Synthesis Limitations: Both sources are reviews. They do not show that sirtuin activity in the human brain is limited by ordinary niacin intake, or that changing that activity improves cognitive energy.
Evidence Considered:
- Study
- Review of NAD⁺ metabolism, including non-redox consumers of the cofactor.
- Population
- No new human cohort.
- Result
- NAD⁺ is required by sirtuins, CD38 and poly(ADP-ribose) polymerases. Ageing-related decline and the benefit of restoring NAD⁺ in people are left unresolved by the review.
- Effect / Magnitude
- No human intake effect size.
- Evidence Summary
- Establishes enzymatic consumption of NAD⁺.
- Limitations
- Does not test diet or cognitive outcomes.
- Evidence Source
- Bounded external search
- Reference
- [1]
- Study
- Review of SIRT1 and other sirtuins in metabolism.
- Population
- No new human feeding cohort.
- Result
- Sirtuins are described as NAD⁺-dependent deacylases that connect metabolic state to protein regulation.
- Effect / Magnitude
- No dietary effect size.
- Evidence Summary
- Supports sirtuins as consumers of NAD⁺.
- Limitations
- A review of enzyme biology is not evidence that dietary niacin changes human cognition.
- Evidence Source
- Inherited repository evidence
- Reference
- [3]
Evidence Dependency:
- Covarrubias et al. (2021) is also the primary source for PM2-F1. Its appearance here is the consumption claim, not a second study.
In mice and cells, the circadian clock controls NAMPT, and NAD⁺ rises and falls with that enzyme. This is not a human sleep-schedule result.
What this means
The salvage enzyme is under clock control in these models. Keeping regular bedtimes has not been shown here to change NAD⁺ in people.
Evidence confidence: Not yet scored
Finding ID: PM2-F3
Finding Statement: Circadian clock factors control NAMPT-mediated NAD⁺ biosynthesis in mice and cells, so NAD⁺ availability oscillates across the day in those systems.
Synthesised Evidence Confidence: Not yet scored
Synthesis: One study reports a feedback cycle in which clock transcription factors control NAMPT and thereby NAD⁺ biosynthesis. A companion study reports that the NAD⁺-dependent deacetylase SIRT1 modulates CLOCK-dependent chromatin control, with NAD⁺ itself changing across the day. Both place the salvage enzyme inside a circadian loop. Neither assigns a bedtime or a meal time.
Synthesis Limitations: The experiments are in mice and cells. They do not show that a regular sleep schedule, or restriction of sleep, changes NAD⁺ in people.
Evidence Considered:
- Study
- Mouse and cell experiments on clock control of NAMPT and NAD⁺.
- Population
- Mice and cultured cells. No human sleep cohort.
- Result
- Clock factors drive Nampt, and NAD⁺ levels oscillate with that control.
- Effect / Magnitude
- A daily oscillation in the model systems. No human effect size.
- Evidence Summary
- Links the clock to nicotinamide salvage in mice.
- Limitations
- Not a test of human sleep timing or dietary niacin.
- Evidence Source
- Inherited repository evidence
- Reference
- [4]
- Study
- Cell and mouse experiments on SIRT1, CLOCK and oscillating NAD⁺.
- Population
- Cultured cells and mice. No human participants.
- Result
- SIRT1 binds the clock machinery and NAD⁺ levels change across the day in the reported system.
- Effect / Magnitude
- No human effect size.
- Evidence Summary
- Connects NAD⁺ consumption by SIRT1 to circadian control in the model.
- Limitations
- Does not test sleep schedules or niacin intake in people.
- Evidence Source
- Inherited repository evidence
- Reference
- [5]
Connected / Supportive Evidence:
- Spiegel et al. (1999) [11] — Human MechanisticWhy relevant: The page had used this sleep-debt experiment as support for NAD⁺ synthesis.Why excluded from the primary synthesis: The study measured glucose tolerance and endocrine responses to sleep debt. It did not measure NAD⁺ or NAMPT.
Five adults with mitochondrial myopathy and low NAD⁺ were given slow-release niacin, increased to 750–1,000 mg a day. Blood NAD⁺ rose, and muscle NAD⁺ reached the level of their controls.
What this means
This is medical dosing in a deficiency disease. It is not evidence that an ordinary diet, or extra niacin once intake is adequate, raises NAD⁺ or helps attention.
Evidence confidence: Not yet scored
Finding ID: PM2-F4
Finding Statement: In adults with mitochondrial myopathy, escalating niacin to 750–1,000 mg/day increased blood NAD⁺ and restored muscle NAD⁺ to the matched-control level, without a cognitive endpoint.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Five adults with adult-onset mitochondrial myopathy and muscle mitochondrial DNA deletions, plus matched controls, received slow-release niacin. The dose started at 250 mg/day and rose to 750–1,000 mg/day. Patients were followed for up to 10 months and controls for 4 months. Blood NAD⁺ increased in the participants who continued, by up to 8-fold, and muscle NAD⁺ in the patients reached the control level. Muscle strength increased. Flushing occurred above 500 mg/day. Two controls stopped because of gastrointestinal irritation.
Synthesis Limitations: The sample is five patients. The dose is far above ordinary niacin intake. There is no untreated comparison group, and attention, cognitive energy and recovery were not endpoints. The result does not transfer to people whose intake is already adequate.
Evidence Considered:
- Study
- Open niacin supplementation in adults with mitochondrial myopathy and in matched controls.
- Population
- Five adults with adult-onset mitochondrial myopathy and matched controls. Two controls discontinued.
- Result
- Blood NAD⁺ rose by up to 8-fold. Muscle NAD⁺ in patients reached the control level. Muscle strength increased. Cognition was not tested.
- Effect / Magnitude
- Up to an 8-fold rise in blood NAD⁺ at 750–1,000 mg/day.
- Evidence Summary
- Pharmacological niacin can rebuild a deficient NAD⁺ pool in this disease.
- Limitations
- Not an ordinary diet, not a randomised untreated comparison, and not a brain or attention outcome.
- Evidence Source
- Inherited repository evidence
- Reference
- [2]
Supports Lifestyle Lever: Aerobic or resistance training
Twelve weeks of aerobic or resistance training increased NAMPT protein in skeletal muscle of young and older adults. The study did not measure NAD⁺ concentration.
What this means
Training changed the amount of the salvage enzyme in muscle. That is not a measurement of the NAD⁺ pool, and it is not a cognitive result.
Evidence confidence: Not yet scored
Finding ID: PM2-F5
Finding Statement: Aerobic and resistance training increased skeletal-muscle NAMPT protein in young and older adults, without a reported change in NAD⁺ concentration.
Synthesised Evidence Confidence: Not yet scored
Synthesis: NAMPT protein in skeletal muscle was lower at older ages across 57 people. Twelve weeks of aerobic training raised muscle NAMPT by about 12% in adults aged 35 or under and by about 28% in adults aged 55 or over. Resistance training raised it by about 25% and 30% in those same age groups. NRK2 and NMNAT1 and NMNAT3 protein did not change. In a separate group, six weeks of high-intensity interval training did not change NAMPT in abdominal fat.
Synthesis Limitations: The endpoint is enzyme protein, not NAD⁺. Muscle NAMPT is not brain NAD⁺. Cognitive energy and recovery were not measured.
Evidence Considered:
- Study
- Twelve-week aerobic and resistance training, with NAMPT and related enzymes measured in muscle biopsies.
- Population
- Adults aged 35 or under and adults aged 55 or over. A separate group provided abdominal fat biopsies.
- Result
- Muscle NAMPT rose after both training modes. Other salvage enzymes in muscle did not. Fat NAMPT did not change after interval training.
- Effect / Magnitude
- About 12–28% after aerobic training and about 25–30% after resistance training, larger in the older groups.
- Evidence Summary
- Training increases the amount of the rate-limiting salvage enzyme in human muscle.
- Limitations
- NAMPT protein is not NAD⁺ concentration and not a cognitive endpoint.
- Evidence Source
- Inherited repository evidence
- Reference
- [6]
A small randomized crossover pharmacokinetic study found altered blood NAD metabolism after single oral NR-chloride doses; separate LC-MS work identified NR in cow milk.
What this means
Dietary nicotinamide riboside can supply the NAD precursor pool through supported salvage reactions, sustaining NAD-availability capacity.
Evidence confidence: Not yet scored
Finding ID: PM2-F8
Finding Statement: A small randomized crossover pharmacokinetic study found altered blood NAD metabolism after single oral NR-chloride doses; separate LC-MS work identified NR in cow milk.
Synthesised Evidence Confidence: Not yet scored
Synthesis: A small randomized crossover pharmacokinetic study found altered blood NAD metabolism after single oral NR-chloride doses; separate LC-MS work identified NR in cow milk.
Synthesis Limitations: Supplemental NR chloride at 100–1000 mg is not an effective milk dose. Blood responses do not establish neuronal or mitochondrial NAD delivery, redox flux, superiority to adequate niacin or clinical benefit. Intestinal metabolism and tissue salvage can differ from the displayed intracellular NRK route; other NAD precursors remain alternatives. Numerical SEC remains pending full-method appraisal; no factor is forced.
Evidence Considered:
- Study
- Single-dose randomized double-blind three-sequence pharmacokinetic crossover, with separate milk-composition analysis.
- Population
- 12 healthy adults in the crossover; the preceding one-person pilot is not independent confirmation.
- Result
- A small randomized crossover pharmacokinetic study found altered blood NAD metabolism after single oral NR-chloride doses; separate LC-MS work identified NR in cow milk.
- Effect / Magnitude
- No additional magnitude inferred.
- Evidence Summary
- A small randomized crossover pharmacokinetic study found altered blood NAD metabolism after single oral NR-chloride doses; separate LC-MS work identified NR in cow milk.
- Limitations
- Supplemental NR chloride at 100–1000 mg is not an effective milk dose. Blood responses do not establish neuronal or mitochondrial NAD delivery, redox flux, superiority to adequate niacin or clinical benefit. Intestinal metabolism and tissue salvage can differ from the displayed intracellular NRK route; other NAD precursors remain alternatives.
- Evidence Source
- Bounded external search
- Reference
- [12]
- Study
- LC-MS/MS and isotope-dilution analysis of raw and commercial cow milk.
- Population
- Milk samples, not an intervention cohort.
- Result
- NR was identified in the studied raw and commercial cow-milk samples.
- Effect / Magnitude
- No additional magnitude inferred.
- Evidence Summary
- NR was identified in the studied raw and commercial cow-milk samples.
- Limitations
- Supplemental NR chloride at 100–1000 mg is not an effective milk dose. Blood responses do not establish neuronal or mitochondrial NAD delivery, redox flux, superiority to adequate niacin or clinical benefit. Intestinal metabolism and tissue salvage can differ from the displayed intracellular NRK route; other NAD precursors remain alternatives.
- Evidence Source
- Bounded external search
- Reference
- [13]
5. BRS Pathways and Connections
5.1 BRS Pathways
- None listed
5.2 Cross-BRS Mechanism Relationships
- BRS-X(Circadian-FM1) — Light and Feeding Zeitgeber Entrainment — molecular clocks regulate NAMPT-dependent NAD⁺ biosynthesis in mice and cells (Ramsey et al., 2009). This supports clock–metabolic feedback, without establishing that a light or meal schedule changes human NAD⁺ availability. NAD⁺ metabolism retains its BRS4 owner.
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS2-FM1-PM4 - Methionine Cycle Flux — One-carbon reactions use redox cofactors. No assessed study shows that this turnover changes how much NAD⁺ cells hold.
- BRS6-FM1-PM2 - Glycaemic Variability Regulation — Carbohydrate oxidation reduces NAD⁺ to NADH. Control of glucose swings is a separate process, and no assessed study shows that those swings change NAD⁺ availability.
5.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS4-FM1-PM1 - Electron Transport Chain Function — NADH made from this pool is what complex I oxidises. The respiratory complexes are a separate mechanism, and niacin precursors belong with this supply.
- BRS4-FM1-PM3 - Creatine–Phosphocreatine Energy Buffering — Oxidative energy production can supply ATP that this buffer stores and releases. No assessed study shows a serial path from this NAD⁺ pool through the respiratory complexes into that buffer.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Rationale: Cybrid cells carrying platelet mitochondria from three boys with ADHD respired less, but NAD⁺ was not measured Verma et al. (2016) [7]. A review of ADHD mitochondrial papers does not add an NAD⁺ measurement Öğütlü et al. (2022) [8].
Supporting evidence
The ADHD cybrid study measured respiration, not NAD⁺. Cognitive energy was not an endpoint.
What this means
Lower respiration in that cell model is not an NAD⁺ result and not evidence that niacin changes cognitive energy.
Evidence confidence: Not yet scored
Finding ID: PM2-F6
Finding Statement: No assessed study measured NAD⁺ availability against cognitive energy. The ADHD cybrid experiment measured respiration without an NAD⁺ or cognitive-energy endpoint.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Verma and colleagues fused platelets from three boys with ADHD with mitochondria-depleted neuronal cells. Those cybrids respired less than control cybrids. The paper does not report NAD⁺ or NADH, and it does not test cognitive energy or diet. A narrative review of ADHD mitochondrial biomarkers does not add an NAD⁺ measurement.
Synthesis Limitations: Absence of an NAD⁺ measurement is not evidence against a biological link. It is evidence that this relationship has not been tested.
Evidence Considered:
- Study
- Cybrid model using platelet mitochondria from boys with ADHD.
- Population
- Three boys with ADHD, aged 10 and 13. No dietary arm.
- Result
- Lower respiration and related mitochondrial changes in the cybrids. No NAD⁺ assay and no cognitive-energy test.
- Effect / Magnitude
- No NAD⁺ effect size.
- Evidence Summary
- The study does not test this pool.
- Limitations
- A respiration result cannot be read as an NAD⁺ or cognitive-energy result.
- Evidence Source
- Inherited repository evidence
- Reference
- [7]
Connected / Supportive Evidence:
- Öğütlü et al. (2022) [8] — Human StudyWhy relevant: Reviews mitochondrial findings in ADHD, which the page had tied to NAD⁺.Why excluded from the primary synthesis: The review does not measure NAD⁺ or cognitive energy.
Informs: Cognitive Energy Stability
- Biology → Phenome Relationship Strength: Low
- Evidence Confidence: Low
- Rationale: The ADHD mitochondrial review discusses mitochondrial strain. It does not measure recovery, and it does not measure NAD⁺ Öğütlü et al. (2022) [8].
Supporting evidence
The ADHD mitochondrial review does not measure recovery and does not measure NAD⁺.
What this means
A narrative link between mitochondrial strain and resilience is not a recovery result for this pool.
Evidence confidence: Not yet scored
Finding ID: PM2-F7
Finding Statement: No assessed study measured NAD⁺ salvage or NAD⁺ availability against recovery capacity.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Öğütlü and colleagues review mitochondrial biomarkers in ADHD. The review does not report a recovery test and does not report NAD⁺. It cannot establish that this pool changes recovery.
Synthesis Limitations: An untested relationship stays unresolved. The review is not evidence that NAD⁺ is irrelevant to recovery.
Evidence Considered:
- Study
- Narrative review of mitochondrial findings in ADHD.
- Population
- No new participants.
- Result
- No NAD⁺ measurement and no recovery endpoint.
- Effect / Magnitude
- No NAD⁺ effect size.
- Evidence Summary
- Does not test this phenome relationship.
- Limitations
- A review of other mitochondrial markers is not an NAD⁺ recovery study.
- Evidence Source
- Inherited repository evidence
- Reference
- [8]
Evidence Dependency:
- Öğütlü et al. (2022) is connected supportive evidence on PM2-F6. Using it here is the same review, not a second measurement.
Informs: Recovery Capacity
8. References
- [1] Covarrubias et al. (2021) — NAD⁺ metabolism and its roles in cellular processes during ageing
- [2] Pirinen et al. (2020) — Niacin and Systemic NAD⁺ Deficiency in Mitochondrial Myopathy
- [3] Chang and Guarente (2014) — SIRT1 and Sirtuins in Metabolism
- [4] Ramsey et al. (2009) — Circadian NAD⁺ Biosynthesis via NAMPT
- [5] Nakahata et al. (2008) — CLOCK–SIRT1 Circadian NAD⁺ Control
- [6] de Guia et al. (2019) — Exercise Training and NAD⁺ Salvage Capacity
- [7] Verma et al. (2016) — Attention Deficit-Hyperactivity Disorder Suffers from Mitochondrial Dysfunction
- [8] Öğütlü et al. (2022) — Mitochondrial Dysfunction in Attention Deficit Hyperactivity Disorder
- [9] Tardy et al. (2020) — A Narrative Review of the Biochemical and Clinical Evidence
- [10] Kyriazis et al. (2022) — Diet Effects on Mitochondrial Physiology
- [11] Spiegel et al. (1999) — Sleep Debt and Metabolic Function
- [12] Trammell et al. (2016) — Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
- [13] Trammell et al. (2016) — Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk
Foods supply the named dietary input. They are not shown as containing the downstream metabolite. Conversion evidence does not establish a new downstream PM admission, effective dose or equivalent food intervention.
Nicotinamide riboside → Human NRK1 phosphorylates beta-NR to beta-NMN using ATP. → Nicotinamide mononucleotide
BRS4-FM1-PM2: Maintain NAD⁺ availability so redox reactions and mitochondrial signalling stay adequately powered.
Existing admission: Type A / derived; versioned-assessment. Production context for an already admitted substrate; no new metabolite-to-PM relationship is admitted.
Supplemental NR chloride at 100–1000 mg is not an effective milk dose. Blood responses do not establish neuronal or mitochondrial NAD delivery, redox flux, superiority to adequate niacin or clinical benefit. Intestinal metabolism and tissue salvage can differ from the displayed intracellular NRK route; other NAD precursors remain alternatives.
- Milk — supplies Nicotinamide riboside; verified; form not known. Raw cow milk from individual cows and commercial cow-milk samples, including skim milk
Composition provenance
An established intracellular route is not proof that all oral NR reaches each tissue intact; parallel degradation/salvage can contribute.
Dependencies: Functional NRK activity; ATP and divalent-metal availability; Tissue access to intact NR
Nicotinamide riboside → Human NRK1 phosphorylates beta-NR to beta-NMN using ATP. → NMN adenylyltransferase adenylates oxidised beta-NMN with ATP to form oxidised NAD. → NAD+ (oxidised nicotinamide adenine dinucleotide)
BRS4-FM1-PM2: Maintain NAD⁺ availability so redox reactions and mitochondrial signalling stay adequately powered.
Existing admission: Type A / derived; versioned-assessment. The complete derived relationship is admitted for this PM.
Supplemental NR chloride at 100–1000 mg is not an effective milk dose. Blood responses do not establish neuronal or mitochondrial NAD delivery, redox flux, superiority to adequate niacin or clinical benefit. Intestinal metabolism and tissue salvage can differ from the displayed intracellular NRK route; other NAD precursors remain alternatives.
- Milk — supplies Nicotinamide riboside; verified; form not known. Raw cow milk from individual cows and commercial cow-milk samples, including skim milk
Composition provenance
An established intracellular route is not proof that all oral NR reaches each tissue intact; parallel degradation/salvage can contribute.
Dependencies: Functional NRK activity; ATP and divalent-metal availability; Tissue access to intact NR
NMNAT1 establishes reaction identity; other isoforms/transport determine compartmental provision. No fixed dietary conversion yield or mitochondrial/brain endpoint is inferred.
Dependencies: Functional NMNAT activity; ATP availability; Compartment-specific precursor access